Status:
RECRUITING
Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes
Lead Sponsor:
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Conditions:
Diabetes Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stress refers to all the reactions of an organism subjected to exogenous or endogenous stress. In the context of diabetes, stress plays a critical role. There are two forms of stress: acute and chroni...
Eligibility Criteria
Inclusion
- Patient who has signed the SMART-T1D free and informed consent form
- Patient able to speak and read French
Exclusion
- Mute patient.
- Patient with severe speech problems that may prevent voice recordings from being made.
Key Trial Info
Start Date :
September 3 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06985862
Start Date
September 3 2025
End Date
February 1 2026
Last Update
October 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CERITD (Centre d'Etudes et de Recherches pour l'Intensification du Traitement du Diabète)
Évry, France, 91058
2
Grenoble University Hospital
Grenoble, France, 38043